Ligand profile
EOZ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_01290 — Aspartate carbamoyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
EOZ- PDB
2fzk- UniProt (similar protein)
P0A786- Target protein
- KP13_01290
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 210.6
- −1 ≤ LogP ≤ 5 -0.38
- MW ≤ 500 Da 396.2
- LogP ≤ 5 -0.38
- H-bond donors ≤ 5 7
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 210.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1c(cc(cc1NC(=O)CP(=O)(O)O)NC(=O)CP(=O)(O)O)C(=O)Oc1c(cc(cc1NC(=O)CP(=O)(O)O)NC(=O)CP(=O)(O)O)C(=O)O
InChI=1S/C11H14N2O10P2/c14-9(4-24(18,19)20)12-7-1-6(11(16)17)2-8(3-7)13-10(15)5-25(21,22)23/h1-3H,4-5H2,(H,12,14)(H,13,15)(H,16,17)(H2,18,19,20)(H2,21,22,23)InChI=1S/C11H14N2O10P2/c14-9(4-24(18,19)20)12-7-1-6(11(16)17)2-8(3-7)13-10(15)5-25(21,22)23/h1-3H,4-5H2,(H,12,14)(H,13,15)(H,16,17)(H2,18,19,20)(H2,21,22,23)
LGLZCZRWQTWLGU-UHFFFAOYSA-NLGLZCZRWQTWLGU-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00185' 'PF02729
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand EOZ →
- PDB RCSB structure 2fzk →
- UniProt UniProt P0A786 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “EOZ”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01290.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).